Commure, a healthcare technology company, announces that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix’s special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior to the closing. Augmedix’s stock has ceased trading and will be delisted from the Nasdaq Stock Market.
Read the full article: Commure Completes Merger with Augmedix //
Source: https://www.globenewswire.com/news-release/2024/10/02/2956933/0/en/Commure-Completes-Merger-with-Augmedix.html